Dr. Heiko Manninga
Dr. Heiko Manninga is Managing Director, CSO at NEUWAY Pharma serving for R&D and related partnering. Dr. Manninga has brought forward the company since its inception and is supported by a stable team of 20 experts as well as staff of experienced consultants to complement in-house experience. In only a year under his leadership, NEUWAY has built up the company and initiated several preclinical projects. Dr. Manninga also established a collaboration with a major pharma-ceutical partner and acquired additional public funding to support the further research program of NEUWAY Pharma.
Dr. Oliver Ernst
Dr. Ernst joined NEUWAY in November 2018 as managing director, also serving for Business Development, Strategic Partnering and Financing, with strong background on Management of Innovation and Intellectual Property. Prior to NEUWAY, Oliver has over ten years of professional experience in the field of Intellectual Property and Innovation Management ranging from private practice to large enterprise. Oliver graduated in biotechnology engineering at the Technical University Berlin and received his PhD at the Fraunhofer Institute for Biomedical Engineering (IBMT).